Physician

Neha Patel, MD

According to 2025 Medicare claims, Neha Patel, MD (NPI: 1184921421) practices allergy/immunology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS, INC. (NPI: 1497182539; TIN: 463233706) and primary practice location at 66061-3155. Patel is affiliated with the Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 40,880 HCPCS/CPT codes, and received $844,044 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 669 prescription claims across 149 beneficiaries totaling $60,341 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 199 claims. Open Payments data shows 8 records totaling $309. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $9,955 to $60,341. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $2,035.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$559K$1.1M2017 Medicare payment: $2,129 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $298,332 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,118,896 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,025,517 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $784,730 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $723,090 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $844,044 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201716192$2,129
2018N/RN/RN/R
201911817,148$298,332
202020762,073$1,118,896
202121040,399$1,025,517
202216830,969$784,730
202319838,551$723,090
202422040,880$844,044

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$58K$116K2015 Drug cost: $9,955 (USD; Tot_Drug_Cst)2016 Drug cost: $11,765 (USD; Tot_Drug_Cst)2017 Drug cost: $1,621 (USD; Tot_Drug_Cst)2018 Drug cost: $4,204 (USD; Tot_Drug_Cst)2019 Drug cost: $24,035 (USD; Tot_Drug_Cst)2020 Drug cost: $43,892 (USD; Tot_Drug_Cst)2021 Drug cost: $46,941 (USD; Tot_Drug_Cst)2022 Drug cost: $116,321 (USD; Tot_Drug_Cst)2023 Drug cost: $72,301 (USD; Tot_Drug_Cst)2024 Drug cost: $60,341 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152884$9,955
20162684$11,765
2017N/R27$1,621
2018N/R31$4,204
201971262$24,035
202076454$43,892
202185456$46,941
2022105554$116,321
2023119530$72,301
2024149669$60,341

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$221K$443K2019 Medicare payment: $3,159 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $141,517 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $275,488 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $326,714 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $353,909 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $442,867 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R11$3,159
2020N/R77$141,517
2021N/R146$275,488
2022N/R161$326,714
2023N/R184$353,909
2024N/R199$442,867

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5353$119
96413Administration of chemotherapy into vein, 1 hour or less55122$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more108216$89
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's92187$12
36415Insertion of needle into vein for collection of blood sample62107$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter321,170$24,929
SymbicortBudesonide/Formoterol Fumarate18960$7,086
EpinephrineEpinephrine26426$3,770
Azelastine HclAzelastine Hcl743,460$2,459
Montelukast SodiumMontelukast Sodium22113,436$1,571

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1555Injection, immune globulin (cuvitru), 100 mgNN/R33$243,280
J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R26$102,226
J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R17$45,867
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mgNN/R13$32,410
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R50$17,142

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$309Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Neha Patel, MD?

Tedicare shows public-source Medicare data for Neha Patel, MD (NPI 1184921421), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neha Patel, MD have ACO affiliation data?

Neha Patel, MD is shown with ACO affiliation data for Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Neha Patel, MD?

Neha Patel, MD is linked to KANSAS CITY PHYSICIAN PARTNERS, INC. (billing NPI 1497182539) in the available physician profile data.

Does Neha Patel, MD have Open Payments data?

Neha Patel, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.